Tyra Biosciences (TYRA) Other Non Operating Income (2022 - 2023)
Tyra Biosciences (TYRA) reported Other Non Operating Income of -$5000.0 for Q3 2023, down 200.0% on a YoY basis from $5000.0 in Q3 2022, and down 200.0% quarter-over-quarter from $5000.0 in Q3 2022.
Tyra Biosciences (TYRA) Other Non Operating Income (2022 - 2023) Analysis & Trends
Tyra Biosciences has reported Other Non Operating Income for 2 years, with the latest figure at -$5000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -5,000.00 |
| Sep 30, 2022 | 5,000.00 |